Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 11-2000 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,251 | 1,336 | 681 | 331 | 411 |
| Accounts receivable | -36 | 2,420 | -1,840 | -238 | 4 |
| Other Working Capital | -2,152 | 4,068 | -1,147 | -162 | 83 |
| Other Operating Activity | -20,214 | -12,958 | 1,456 | -7,177 | -6,263 |
| Operating Cash Flow | $-20,151 | $-5,134 | $-850 | $-7,246 | $-5,766 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -396 | -2,260 | -4,139 | -710 | -597 |
| Purchase Of Investment | N/A | -9,815 | -18,238 | N/A | -6,471 |
| Sale Of Investment | 2,032 | N/A | N/A | 3,577 | N/A |
| Other Investing Activity | -656 | -2,338 | -445 | -359 | -185 |
| Investing Cash Flow | $980 | $-14,414 | $-22,823 | $2,508 | $-7,253 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 126 | 25,543 | 12,451 | 30,384 | 15,975 |
| Common Stock Repurchased | N/A | -641 | -205 | N/A | N/A |
| Other Financing Activity | 4,740 | -284 | 130 | 26 | -83 |
| Financing Cash Flow | $4,865 | $24,618 | $12,376 | $30,409 | $15,892 |
| Exchange Rate Effect | -612 | -1,546 | N/A | N/A | N/A |
| Beginning Cash Position | 29,799 | 24,100 | 31,148 | 5,131 | 2,448 |
| End Cash Position | 14,881 | 27,624 | 19,851 | 30,803 | 5,321 |
| Net Cash Flow | $-14,305 | $5,070 | $-11,297 | $25,671 | $2,873 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,151 | -5,134 | -850 | -7,246 | -5,766 |
| Capital Expenditure | -870 | -2,260 | -4,624 | -775 | -603 |
| Free Cash Flow | -21,021 | -7,395 | -5,474 | -8,021 | -6,369 |